Trial Profile
A Study to Evaluate the Efficacy of Combined Intravitreal Bevacizumab and Macular Grid and Scatter Laser Photocoagulation in the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 10 Feb 2016 New trial record